Paul Juengel, MD
Otolaryngology · Mebane, NCNPI 1700873940
Payments from drug & device makers
Across 61 payments — averaging $19.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Optinose US, Inc.$293
- Regeneron Healthcare Solutions, Inc.$160
- GSK$141
- Acclarent, Inc$121
- Sanofi$111
- Kaleo, Inc.$87
- plus $303 from 11 others
What the payments were for
- Food & beverage$1,216100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Optinose US, Inc. | 20 | $293 |
| Regeneron Healthcare Solutions, Inc. | 6 | $160 |
| GSK | 7 | $141 |
| Acclarent, Inc | 3 | $121 |
| Sanofi | 6 | $111 |
| Kaleo, Inc. | 5 | $87 |
| Integra Lifesciences Corporation | 1 | $75 |
| Aerin Medical Inc. | 3 | $41 |
| Stryker | 2 | $35 |
| Merck | 1 | $26 |
| USWM, LLC | 1 | $22 |
| Phadia US Inc. | 1 | $20 |
| Alk-abello, Inc | 1 | $19 |
| Intersect ENT, Inc. | 1 | $18 |
| Pfizer | 1 | $17 |
| Itamar Medical Inc | 1 | $15 |
| Inspire Medical Systems, Inc. | 1 | $15 |
How this compares
$1,216 in reported general payments places this provider in the 50th percentile of 362 otolaryngology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mometasone Furoate | 36 | $4,162 |
| Epinephrine | 18 | $2,872 |
| Fluticasone Propionate | 48 | $1,028 |
| Montelukast Sodium | 77 | $946 |
| Levothyroxine Sodium | 132 | $881 |
| Fluocinolone Acetonide Oil | 23 | $673 |
| Ipratropium Bromide | 15 | $397 |
| Liothyronine Sodium | 20 | $388 |
| Azithromycin | 15 | $329 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 12 | $283 |
| Prednisone | 84 | $257 |
| Cephalexin | 14 | $217 |
| Omeprazole | 13 | $179 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 22 | $142 |
| Clindamycin Hcl | 11 | $108 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Mebane
- Robert FerrisRaleigh$2.5M
- David JangDurham$1M
- Mark WeigelHuntersville$275K
- Stephen PottsWinston Salem$242K
- Adam ZanationHickory$227K
- Anne SelleckChapel Hill$165K
- Jonathan MossMatthews$164K
- William ScurryWinston Salem$162K
- James MimsWinston Salem$114K
- Stephen HarperWinston Salem$92K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.